National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 50630-50631 [E8-19798]

Download as PDF 50630 Federal Register / Vol. 73, No. 167 / Wednesday, August 27, 2008 / Notices TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued 21 CFR Section No. of Respondents Form No. Annual Frequency per Response Total Annual Responses Hours per Response Total Hours Guidance Use of Recycled Plastics in Food Packaging: Chemistry Considerations 10 1 10 25 Total 250 37,975 1 There sroberts on PROD1PC70 with NOTICES are no capital costs or operating and maintenance costs associated with this collection of information. 2 Notifications for food contact substance formulations and food contact articles. These notifications require the submission of FDA Form 3479 (‘‘Notification for a Food Contact Substance Formulation’’) only. 3 Duplicate notifications for uses of food contact substances. 4 Notifications for uses that are the subject of exemptions under 21 CFR 170.39 and very simple food additive petitions. 5 Notifications for uses that are the subject of moderately complex food additive petitions. 6 Notifications for uses that are the subject of very complex food additive petitions. 7 These notifications require the submission of FDA Form 3480. These estimates are based on FDA’s experience with the food contact substances notification system. Based on input from industry sources, FDA estimates that approximately five respondents will submit one notification annually for food contact substance formulations (Form FDA 3479), for a total of five responses. FDA estimates the reporting burden to be 2.0 hours per response, for a total burden of 10 hours. FDA also has included five expected duplicate submissions in the second row of table 1 of this document. FDA expects that the burden for preparing these notifications primarily will consist of the manufacturer or supplier filling out FDA Form 3480, verifying that a previous notification is effective and preparing necessary documentation. Thus, FDA estimates that five respondents will submit one such submission annually, for a total of five responses. FDA estimates the reporting burden to be 25.0 hours per response, for a total burden of 125 hours. Based on the submissions received, FDA identified three other tiers of FCNs that represent escalating levels of burden required to collect information (denoted as Categories C, D, and E in the third, fourth, and fifth rows of table 1 of this document). FDA estimated the median number of hours necessary for collecting information for each type of notification within each of the three tiers based on input from industry sources. FDA estimates that five respondents will submit two Category C submissions annually, for a total of ten responses. FDA estimates the reporting burden to be 120 hours per response, for a total burden of 1,200 hours. FDA estimates that 33 respondents will submit 2 Category D submissions annually, for a total of 66 responses. FDA estimates the reporting burden to be 150 hours per response, for a total VerDate Aug<31>2005 18:52 Aug 26, 2008 Jkt 214001 burden of 9,900 hours. FDA estimates that 30 respondents will submit 1 Category E submission annually, for a total of 30 responses. FDA estimates the reporting burden to be 150 hours per response, for a total burden of 4,500 hours. FDA estimates that two respondents will submit one indirect food additive petition under § 171.1, for a total of two responses. FDA estimates the reporting burden to be 10,995 hours per response, for a total burden of 21,990 hours. FDA estimates that 10 respondents will utilize the recommendations in the guidance document entitled ‘‘Use of Recycled Plastics in Food Packaging: Chemistry Considerations,’’ to develop the additional information for one such submission annually, for a total of 10 responses. FDA estimates the reporting burden to be 25 hours per response, for a total burden of 250 hours. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at https://www.regulations.gov. Dated: August 20, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8–19843 Filed 8–26–08; 8:45 am] BILLING CODE 4160–01–S PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Subcommittee I— Career Development, September 30, 2008, 8 a.m. to October 1, 2008, 5 p.m., Crowne Plaza National Airport, 1480 Crystal Drive, Arlington, VA, 22202 which was published in the Federal Register on August 8, 2008, 73 FR 46308. This meeting is amended to change the meeting date to September 30, 2008. The meeting is closed to the public. Dated: August 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–19805 Filed 8–26–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, E:\FR\FM\27AUN1.SGM 27AUN1 Federal Register / Vol. 73, No. 167 / Wednesday, August 27, 2008 / Notices sroberts on PROD1PC70 with NOTICES and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel. A Cooperative Research Partnerships for Biodefense, and Emerging Infectious Diseases SEP 1. Date: September 15, 2008. Time: 11 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, 3122, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review Officer, NIAID, DEA, Scientific Review Program, Room 3122, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, (301) 451–3684, bgustafson@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel, A Cooperative Research Partnerships for Biodefense, and Emerging Infectious Diseases SEP 2. Date: September 18, 2008. Time: 11 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, 3122, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review Officer, NIAID, DEA, Scientific Review Program, Room 3122, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, (301) 451–3684, bgustafson@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel, Regional Centers of Excellence for Biodefense, and Emerging Infectious Diseases-September. Date: September 22–24, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Hotel Washington DC/ Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Darren D Sledjeski, PhD, Scientific Review Officer, National Institutes of Health/NIAID, Scientific Review Program, 6700-B Rockledge Drive, MSC–7616 Room 3131, Bethesda, MD 20892–7616, (301) 451– 2638, sledjeskid@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel, Regional Centers of Excellence for Biodefense, and Emerging Infectious Diseases. Date: October 6–8, 2008. Time: 7:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Rd., Bethesda, MD 20852. Contact Person: Darren D Sledjeski, PhD, Scientific Review Officer, National Institutes of Health/NIAID, Scientific Review Program, VerDate Aug<31>2005 18:52 Aug 26, 2008 Jkt 214001 6700-B Rockledge Drive, MSC–7616 Room 3131, Bethesda, MD 20892–7616, (301) 451– 2638, sledjeskid@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–19798 Filed 8–26–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Commiftee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of R03’s. Date: October 22, 2008. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Victor Henriquez, PhD, Scientific Review Officer, DENSRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 20892–4878, 301–594–3169. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: August 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Commiftee Policy. [FR Doc. E8–19799 Filed 8–26–08; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 50631 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Amended Notice of Meeting Notice is hereby given of a correction in Interagency Autism Coordinating Committee (IACC), Services Subcommittee Conference Call and Webinar, September 15, 2008, 9:30 a.m. to 11:30 a.m., which was published in the Federal Register on August 15, 2008, 73 FR 47958. The correct meeting access code is 3857872. Everything else remains the same. Dated: August 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–19804 Filed 8–26–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Solicitation of Proposal Information for Award of Public Contracts Office of the Chief Procurement Officer, Acquisition Policy and Legislation Office, DHS. ACTION: 30-Day Notice and request for comments: Extension without change of a currently approved collection, 1600– 0005. AGENCY: SUMMARY: The Department of Homeland Security, Office of the Chief Procurement Officer, Acquisition Policy and Legislation Office, will submit the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13 (as amended), 44 U.S.C. Chapter 35). The Office of the Chief Procurement Officer is soliciting comments related to its request for extension of an existing information collection authority for the solicitation of proposal information for award of public contracts under Homeland Security Acquisition Regulation (HSAR). DHS previously published this information collection request (ICR) in the Federal Register on June 6, 2008 at 73 FR 32343, for a 60day public comment period. No comments were received by DHS. The purpose of this notice is to allow additional 30-days for public comments. DATES: Comments are encouraged and will be accepted until September 26, E:\FR\FM\27AUN1.SGM 27AUN1

Agencies

[Federal Register Volume 73, Number 167 (Wednesday, August 27, 2008)]
[Notices]
[Pages 50630-50631]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-19798]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material,

[[Page 50631]]

and personal information concerning individuals associated with the 
grant applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel.
    A Cooperative Research Partnerships for Biodefense, and Emerging 
Infectious Diseases SEP 1.
    Date: September 15, 2008.
    Time: 11 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
3122, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review 
Officer, NIAID, DEA, Scientific Review Program, Room 3122, 6700-B 
Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, (301) 451-3684, 
bgustafson@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel, A Cooperative Research 
Partnerships for Biodefense, and Emerging Infectious Diseases SEP 2.
    Date: September 18, 2008.
    Time: 11 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
3122, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review 
Officer, NIAID, DEA, Scientific Review Program, Room 3122, 6700-B 
Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, (301) 451-3684, 
bgustafson@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel, Regional Centers of Excellence for 
Biodefense, and Emerging Infectious Diseases-September.
    Date: September 22-24, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza Hotel Washington DC/Silver Spring, 8777 
Georgia Avenue, Silver Spring, MD 20910.
    Contact Person: Darren D Sledjeski, PhD, Scientific Review 
Officer, National Institutes of Health/NIAID, Scientific Review 
Program, 6700-B Rockledge Drive, MSC-7616 Room 3131, Bethesda, MD 
20892-7616, (301) 451-2638, sledjeskid@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel, Regional Centers of Excellence for 
Biodefense, and Emerging Infectious Diseases.
    Date: October 6-8, 2008.
    Time: 7:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Rd., Bethesda, MD 20852.
    Contact Person: Darren D Sledjeski, PhD, Scientific Review 
Officer, National Institutes of Health/NIAID, Scientific Review 
Program, 6700-B Rockledge Drive, MSC-7616 Room 3131, Bethesda, MD 
20892-7616, (301) 451-2638, sledjeskid@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 20, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-19798 Filed 8-26-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.